HPM
GILD icon

Hoxton Planning & Management’s Gilead Sciences GILD Stock Holding History

Hoxton Planning & Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Sell
3,039
-15
-0.5% -$1.98K 0.1% 149
2026
Q1 		$426K Buy
3,054
+15
+0.5% +$2.1K 0.13% 124
2025
Q4 		$373K Buy
3,039
+2
+0.1% +$243 0.11% 133
2025
Q3 		$337K Sell
3,037
-367
-11% -$41.7K 0.11% 141
2025
Q2 		$377K Sell
3,404
-409
-11% -$43.5K 0.13% 133
2025
Q1 		$427K Sell
3,813
-70
-2% -$7.22K 0.16% 121
2024
Q4 		$359K Buy
3,883
+3
+0.1% +$270 0.14% 132
2024
Q3 		$325K Buy
3,880
+480
+14% +$36.6K 0.13% 144
2024
Q2 		$233K Buy
3,400
+548
+19% +$36.6K 0.11% 141
2024
Q1 		$209K Buy
2,852
+9
+0.3% +$692 0.1% 156
2023
Q4 		$230K Sell
2,843
-62
-2% -$4.83K 0.12% 130
2023
Q3 		$218K Sell
2,905
-84
-3% -$6.46K 0.14% 126
2023
Q2 		$230K Sell
2,989
-485
-14% -$38.7K 0.14% 125
2023
Q1 		$288K Sell
3,474
-103
-3% -$8.53K 0.16% 118
2022
Q4 		$307K Buy
+3,577
New +$283K 0.16% 118

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Hoxton Planning & Management's GILD Position: Q2 2026 in Review

Hoxton Planning & Management reduced its Gilead Sciences (GILD) stake by 0.49% in Q2 2026, selling an estimated $1.98K and leaving 3,039 shares worth $384K. The position accounts for 0.1% of the portfolio, ranked #149.

Hoxton Planning & Management first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $427K in Q1 2025. 486 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hoxton Planning & Management held 3,039 shares of Gilead Sciences worth $384K as of Q2 2026.
  • Hoxton Planning & Management sold 15 Gilead Sciences shares in Q2 2026, an estimated $1.98K.
  • Gilead Sciences made up 0.1% of Hoxton Planning & Management's portfolio in Q2 2026, its #149 holding.
  • Hoxton Planning & Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Hoxton Planning & Management's Gilead Sciences position peaked at $427K in Q1 2025.
  • 486 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hoxton Planning & Management's 13F filing for Q2 2026, filed 16 Jul 2026.